Type 2 Diabetes: TRANSCEND-T2D-1 In March 2026, Eli Lilly published topline results from TRANSCEND-T2D-1 the Phase 3 trial of retatrutide in adults with type 2 diabetes
CNS dopamine oxidation and catechol-O-methyltransferase: Importance in the etiology, pharmacotherapy, and dietary prevention of Parkinsons disease
Jardiance is used in adults for specific approved cardiometabolic uses, including type 2 diabetes with diet and exercise, and certain heart failure or chronic kidney disease risk-reduction uses
however, radiation-induced toxicity to healthy organs, especially the bone marrow, remains a major limitation 65
Tear fluid was collected from 60 participants, cognitively normal (CN) individuals ( n = 32), patients with mild cognitive impairment ( n = 14), and dementia ( n = 14)